Sumatriptan Sun

Sumatriptan Sun is a prescription medication used for acute migraine relief. It belongs to the triptan class of drugs and comes in subcutaneous form. This product is manufactured by Sun Pharmaceutical Industries Europe B.V. and is available in the EU market.

Sumatriptan Sun is primarily used to treat acute migraine headaches in adults. It works by narrowing blood vessels around the brain to relieve pain. This medication is not intended for preventive migraine treatment but for relieving symptoms once a migraine has started. It may also be used to treat cluster headaches.

Sumatriptan Sun typically reduces migraine symptoms such as headache pain, nausea, and sensitivity to light and sound. Users may experience relief within 10 to 15 minutes after injection. Some individuals report feeling drowsiness or dizziness after administration.

Sumatriptan Sun should be used with caution in individuals with a history of heart disease or high blood pressure. It is important to follow healthcare provider instructions and avoid overuse. Patients should inform their doctor if they have risk factors for heart disease before starting this medication.

Sumatriptan Sun may interact with other medications, particularly those affecting serotonin levels, such as SSRIs or SNRIs. Combining it with ergot-containing drugs or other triptans can increase the risk of side effects. Alcohol and certain herbal supplements may also interact with this medication.